Activate Multilineage Defense Against Infection

LEUKINE® (sargramostim) is the first and only FDA-approved GM-CSF1

GM-CSF=granulocyte-macrophage colony-stimulating factor.

The unique multipotent biology of LEUKINE stimulates multiple immune cell types1

Explore the mechanism

Take a brief survey about your treatment approaches after transplant

A donation will be made upon completion of the survey to support patients navigating the transplant journey.

Take the survey